Early and Persistent Human Immunodeficiency Virus Type 1 (HIV-1)-specific T Helper Dysfunction in Blood and Lymph Nodes Following Acute HIV-1 Infection
Overview
Affiliations
Without potent antiretroviral therapy, most human immunodeficiency virus type 1 (HIV-1)-infected persons experience a progressive decline in CD4+ T cells and impairment in T helper function. It is unclear how soon after infection T cell dysfunction occurs. T helper responses were examined in blood and lymphoid tissue of 39 untreated patients with acute HIV-1 infection. Within the first 3 months, lymphoproliferative responses to mitogen, recall antigens, and HIV-1 antigens were impaired. After 6-9 months, responses to phytohemagglutinin and recall antigens improved. However, HIV-1-specific lymphoproliferation remained largely undetectable throughout 2 years of infection, and results were similar upon evaluation of lymphoid cells. Rare patients with HIV-1-specific responses had significantly lower plasma HIV-1 RNA levels than did nonresponders. These results indicate that T helper dysfunction occurs early after HIV-1 acquisition and that untreated individuals rarely recover HIV-specific helper responses; these findings lend support for early therapeutic intervention to prevent the destruction and further impairment of the T helper cells.
Schreurs R, Koulis A, Booiman T, Boeser-Nunnink B, Cloherty A, Rader A Nat Commun. 2024; 15(1):2465.
PMID: 38548722 PMC: 10979031. DOI: 10.1038/s41467-024-46606-z.
Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.
Valenzuela-Fernandez A, Cabrera-Rodriguez R, Casado C, Perez-Yanes S, Pernas M, Garcia-Luis J Biomedicines. 2022; 10(9).
PMID: 36140273 PMC: 9495913. DOI: 10.3390/biomedicines10092172.
Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals.
Shindiapina P, Ahmed E, Mozhenkova A, Abebe T, Baiocchi R Front Oncol. 2020; 10:1723.
PMID: 33102204 PMC: 7556212. DOI: 10.3389/fonc.2020.01723.
Liu A, Lohman-Payne B, Chung M, Kiarie J, Kinuthia J, Slyker J Clin Exp Immunol. 2015; 180(3):509-19.
PMID: 25652232 PMC: 4449779. DOI: 10.1111/cei.12599.
HIV persistence: chemokines and their signalling pathways.
Evans V, Khoury G, Saleh S, Cameron P, Lewin S Cytokine Growth Factor Rev. 2012; 23(4-5):151-7.
PMID: 22749173 PMC: 4062707. DOI: 10.1016/j.cytogfr.2012.05.002.